Gyógyszerkibocsátó stent alkalmazása arteria mesenterica superior in-stent restenosisában

Translated title of the contribution: Use of a drug-eluting stent for the treatment of in-stent restenosis of the superior mesenteric artery

Réka P. Szabó, Mózes Péter, István Varga, Gusztáv Vajda, Mariann Harangi, János Mátyus, József Balla

Research output: Contribution to journalArticle

Abstract

INTRODUCTION - Diagnosis and treating intestinal ischaemia in time presents a great challenge for clinicians. CASE REPORT - In a 60-year-old woman on dialysis who presented with abdominal angina, angiography revealed stenosis of the superior mesenteric artery, which was treated by implantation of a 6×29 mm Genesis stent. After a year, her symptoms reoccurred and angiography revealed restenosis, which was treated with a 7×34 mm Wallstent, while her previous acetylsalicylic acid treatment was supplemented with clopidrogel. Nevertheless, her abdominal angina reoccurred again after a year. During the next intervention - because of the in-stent restenosis - a Taxus Liberte stent was implanted. During the dual antiplatelet therapy, her abdominal complaints did not reoccur, her body weight increased and angiography did not reveal restenosis in the affected artery even after 4 years. CONCLUSIONS - A drug-eluting stent can be a good choice in case of restenosis of the superior mesenteric artery. In a stented patient, it is crucial to use an appropriately controlled, long-term, dual antiplatelet therapy.

Original languageHungarian
Pages (from-to)423-427
Number of pages5
JournalLege Artis Medicinae
Volume22
Issue number6-7
Publication statusPublished - Oct 8 2012

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this